Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03534375 · ClinicalTrials.gov registry record
Gender Differences of Neuroanatomical and Neurophysiological Correlates of Risk-proneness in Early Adolescents
A clinical trial, sponsored by Texas Tech University.
- Completed
- Registry status
- 8
- Enrollment target
NCT03534375: Completed study, sponsored by Texas Tech University.
NCT03534375 is a clinical trial that has completed, run by Texas Tech University. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03534375 has completed, sponsored by Texas Tech University.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Risk-taking in early adolescence have has been found to be normative and even formative as it might fulfill the youth's needs to experiment different sensations, make independent decisions and learn from their consequences. Several theoretical models have suggested that male and female adolescents differ in risk-taking as a product of individual/contextual factors and neocortical functioning; however, the neurophysiological and neuropsychological correlates of those differences continue to be underexplored. Informed by Evolutionary Neuroandrogenic Theory, the investigators examine the links between gender, risk-proneness, gratification delay, self-control, self-efficacy, executive functions and neurophysiological-neuroanatomical correlates in early adolescents (age 10-12 years). Participants (N=24; 50% females) will complete behavioral measurements on study constructs and perform neuropsychological tests using fMRI scanning (e.g., Go/NoGo continuous performance, stop-signal reaction time, NIH Cognition Battery, delay discounting). Female and male groups will be compared on all outcome measures.
Primary Outcome
Female vs. male differences of functional magnetic resonance imaging reactivity of the whole brain while performing a Stop Signal Reaction Time Task
Interventions
- OTHER The study is an observational cross sectional study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-05-14 |
| Est. Completion | 2019-08-31 |
What the finished NCT03534375 record still lists
NCT03534375 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which The study is an observational cross sectional study is the first listed.
NCT03534375 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03534375 about?
NCT03534375 is a clinical study titled "Gender Differences of Neuroanatomical and Neurophysiological Correlates of Risk-proneness in Early Adolescents". Risk-taking in early adolescence have has been found to be normative and even formative as it might fulfill the youth's needs to experiment different sensations, make independent decisions and learn from their consequences. Several theoretical models have suggested that male and female adolescents d...
What is the current status of trial NCT03534375?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2018-05-14. Estimated completion is 2019-08-31.
What interventions are being tested in trial NCT03534375?
The interventions under investigation include: The study is an observational cross sectional study (OTHER).
Who is sponsoring clinical trial NCT03534375?
This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI